SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-197059
Filing Date
2017-06-07
Accepted
2017-06-07 16:12:20
Documents
4
Period of Report
2017-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d392466d8k.htm 8-K 21008
2 EX-10.1 d392466dex101.htm EX-10.1 269680
3 EX-99.1 d392466dex991.htm EX-99.1 12207
4 GRAPHIC g392466g42h63.jpg GRAPHIC 4390
  Complete submission text file 0001193125-17-197059.txt   310690
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 17897379
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10